Neogen Corporation's Benzylpiperazine ELISA (Enzyme-Linked ImmunoSorbent Assay) test kit is a qualitative one-step kit designed for use as a screening device for the detection of Benzylpiperazine and/or their metabolites. The kit was designed for screening purposes and is intended for forensic use only.
Intended Use
For the determination of trace quantities of Benzylpiperazine and/or other metabolites in human urine, blood or oral fluid. Contact a Neogen representative for information on other matrices.
Sensitivity
Compound | I-50 in EIA Buffer |
Benzylpiperazine | 0.74 ng/mL |
Specificity (Cross-Reactivity)
Compound | Cross-Reactivity |
Benzylpiperazine | 100% |
1-(3-Trifluoromethyl)benzyl)piperazine) | 3.0% |
1-(4-Trifluoromethyl)benzyl)piperazine) | 1.0% |
Trazodone | 1.0% |
Nefazodone | 0.20% |
Doxepin | 0.13% |
Chlorpromazine | 0.07% |
m-CPP | 0.07% |
Isoxsuprine | 0.05% |
Pyrantel | 0.03% |
N-[3-(Trifluoromethyl)phenyl]piperazine | 0.03% |
Imipramine | 0.02% |
Acepromazine | 0.02% |
Orphenadrine | 0.01% |
Amitriptyline | 0.01% |
Nicotine | 0.01% |
Order Details
Product # | Product Description |
108319 | Benzylpiperazine, 96 well kit |
108316 | Benzylpiperazine, 480 well kit |
For forensic use only.